EN
CNEN

AIMTB Assay

Specification:96T/set
Accuracy:Inter-assay Precision: Coefficient of variation (CV) ≤10%.
Performance:Positive coincidence rate of QFT is 98.12%; Negative coincidence rate of QFT is 91.65%.

Description:

AIMTB utilizes the IGRA principle to accurately determine the presence of specific T-cell responses against Mycobacterium tuberculosis. AIMTB comes in three forms, AIMTB-ELISA, AIMTB-FLF or AIMTB-CLIA. AIMTB-ELISA has NMPA approval and CE certified. Both AIMTB-FLF and AIMTB-CLIA are CE certified and expected to gain NMPA approval in 2023.

Product DetailsFeaturesApplications



AIMTB Enzyme-linked Immunosorbent Assay Platform

① Enhanced Sensitivity

This platform can detect both pulmonary and extrapulmonary tuberculosis cases with a detection rate exceeding 90% in tuberculosis patients.

② Superior Specificity

This platform effectively mitigates interference from the BCG vaccine and most non-tuberculous mycobacteria, ensuring high specificity in tuberculosis detection.

③ Streamlined Sampling Process

Simplifies the sampling procedure by utilizing whole blood, this approach eliminates the impact of the patient's bacterial load or the stage of infection, ensuring consistent and reliable test results.

Swift and Efficient Detection

Results available within 24 hours, this platform eliminates the need for repeated visits.




AIMTB (FLF, Fluorescence Lateral Flow)

Outstanding Performance

The AIMTB Fluorescence Immunochromatography Platform delivers exceptional performance with a sensitivity range of 85%-95% and a specificity range of 93%-99%. It remains unaffected by interference from the BCG vaccine and most non-tuberculous mycobacteria, ensuring reliable and accurate results.

Simplified Operation

Designed as a Point-of-Care Testing (POCT) platform, the AIMTB Fluorescence Immunochromatography Platform offers rapid detection, providing results within 15 minutes. This eliminates the need for repeated calibration and incorporates automatic result interpretation, simplifying the entire testing process.

Cost-Effective Solution

The platform's room temperature storage and transportation feature significantly reduces storage costs. Moreover, its straightforward operation minimizes labor costs, making it a cost-effective choice for tuberculosis diagnostics.



Screening for latent tuberculosis infection and aiding in the diagnosis of active tuberculosis disease.


Official WeChat
Service hotline:
+86 20 82113921

Add:7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China